Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Jennifer Good — FY2025 total compensation $3,944,892

Jennifer Good is President and Chief Executive Officer of Trevi Therapeutics, Inc. (TRVI). The company reported total compensation of $3,944,892 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$622,382
Bonus$343,750
Stock awards$0
Option awards$2,968,260
Non-equity incentive plan$0
Pension and non-qualified deferred compensation$0
All other compensation$10,500
Total$3,944,892

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Trevi Therapeutics, Inc. filed April 21, 2026, accession 0001193125-26-166695.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025President and Chief Executive Officer$622,382$343,750$0$2,968,260$0$0$10,500$3,944,892
FY2024President and Chief Executive Officer$607,930$368,974$0$1,601,781$0$0$10,350$2,589,035

Totals as disclosed in each year's own compensation disclosure for Trevi Therapeutics, Inc..

03

Peer context

Peer-group chief executive median$6,133,943
Difference from that median$-2,189,051
Percentile within the disclosed peer group15th
Peers with a disclosed figure13

Medians and percentiles are computed across the peer group Trevi Therapeutics, Inc. discloses in its own compensation disclosure.

04

The other named executive officers of Trevi Therapeutics, Inc.

Named executive officerRoleFY2025 total
Jennifer Good this pagePresident and Chief Executive Officer$3,944,892
James CassellaChief Development Officer$1,637,220
Farrell SimonChief Commercial Officer$1,355,897

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Trevi Therapeutics, Inc. compensation brief.

05

The company page

Jennifer Good's compensation sits inside Trevi Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Trevi Therapeutics, Inc. (TRVI) compensation brief